Trials / Sponsors / J Ints Bio
J Ints Bio
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Phase I, FIH, MTD for MPT0B640, Multi-centre, Open-label, Subject With Locally Advanced or Metastatic Solid Ma Advanced Solid Tumor, Metastatic Solid Tumor | EARLY_Phase 1 | 2025-12-01 |
| Recruiting | A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced EGFR Mutant Advanced Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2023-07-30 |
| Withdrawn | Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection Covid19 | Phase 1 | 2021-12-01 |